Coenzyme Q10

← Back to Lab Reference Library

Category: Longevity and Aging  |  Also known as: CoQ10, Ubiquinone, Ubiquinol, Coenzyme Q  |  Sample: Serum (fasting preferred; take with fat-containing meal for accurate supplemented levels)

1. What This Test Measures

Coenzyme Q10 (CoQ10) is a fat-soluble, vitamin-like compound present in virtually every cell in the body. It occupies a unique position in cellular biochemistry by serving two critical functions simultaneously. First, CoQ10 is the essential electron carrier in the mitochondrial electron transport chain (ETC), shuttling electrons from Complex I and Complex II to Complex III. Without adequate CoQ10, the ETC stalls and ATP production drops. Because 90% of the body's ATP is produced through oxidative phosphorylation in the ETC, CoQ10 depletion directly reduces the energy available for muscle contraction, neuronal signaling, cardiac output, immune function, and every other energy-dependent process.

Second, CoQ10 functions as one of the body's most important lipid-soluble antioxidants. In its reduced form (ubiquinol), it donates electrons to neutralize reactive oxygen species (ROS) in cell membranes, mitochondrial membranes, and circulating LDL particles. This antioxidant function protects against lipid peroxidation, LDL oxidation (a driver of atherosclerosis), and mitochondrial DNA damage (a hallmark of aging).

CoQ10 exists in two interconvertible forms: ubiquinone (oxidized form, carrying electrons to Complex III) and ubiquinol (reduced form, functioning as an antioxidant and as the bioavailable supplemental form). The serum CoQ10 test measures total CoQ10 (ubiquinone plus ubiquinol). Serum CoQ10 levels reflect both dietary intake, endogenous synthesis (produced through the mevalonate pathway in every cell), and the balance between utilization and replacement.

2. Why This Test Matters

• Mitochondrial energy production: CoQ10 is required for ATP synthesis. Every cell in the body depends on CoQ10 for energy. Organs with the highest energy demands (heart, brain, skeletal muscle, liver, kidneys) are the most vulnerable to CoQ10 depletion
• Statin medication monitoring: statins inhibit HMG-CoA reductase, reducing CoQ10 synthesis by 40 to 50%. This explains the myalgia, fatigue, and exercise intolerance reported by 10 to 30% of statin users. CoQ10 monitoring should be standard for all statin patients
• Cardiovascular function: the heart beats approximately 100,000 times per day and is the most mitochondria-dense organ. CoQ10 deficiency impairs cardiac contractility, and supplementation has demonstrated benefit in heart failure trials (the Q-SYMBIO trial showed 43% reduction in cardiovascular mortality with CoQ10 supplementation)
• Antioxidant defense: CoQ10 (as ubiquinol) protects LDL particles from oxidation. Oxidized LDL is the form that drives atherosclerotic plaque formation. CoQ10 depletion increases the proportion of LDL that becomes oxidized
• Aging biomarker: endogenous CoQ10 production declines with age, and tissue CoQ10 concentrations in the heart decrease approximately 50% between ages 20 and 80. This decline parallels the increase in mitochondrial dysfunction that drives biological aging
• Fertility: CoQ10 plays a role in egg quality and sperm motility. CoQ10 supplementation has been studied in both male and female fertility protocols
• Neurological function: neurons have high energy demands and are vulnerable to mitochondrial decline. CoQ10 supports neuronal energy production and protects against oxidative damage in neurodegenerative conditions

3. Standard Lab Reference Range

CoQ10 Level	Conventional Classification	Clinical Notes
Below 0.4 mcg/mL	Deficient	Significant depletion; impaired ETC function likely
0.4 to 1.0 mcg/mL	Low normal	Functional depletion possible; symptomatic in high-demand tissues
1.0 to 1.9 mcg/mL	Normal	Standard reference range; FM optimal begins above 1.5
Above 1.9 mcg/mL	High normal	Often seen with supplementation; no toxicity at physiological levels

4. Optimal Functional Medicine Range

CoQ10 Level	Functional Interpretation
Below 0.8 mcg/mL	Deficient: supplementation indicated regardless of symptoms; impaired energy production and antioxidant capacity
0.8 to 1.4 mcg/mL	Suboptimal: functional depletion in high-demand tissues (heart, brain, muscle); supplementation recommended
1.5 to 2.5 mcg/mL	Optimal: adequate for ETC function and antioxidant protection in most patients
Above 2.5 mcg/mL	Therapeutic: target for patients on statins, with heart failure, or with documented mitochondrial dysfunction

5. CoQ10 in the Complete Mitochondrial Panel

CoQ10 is one component of a comprehensive mitochondrial and cardiovascular assessment:

Marker	What It Adds	FM Optimal
CoQ10 (this page)	ETC electron carrier status; antioxidant capacity	Above 1.5 mcg/mL
Fasting Insulin	Metabolic status; insulin resistance impairs mitochondrial function	2 to 6 uIU/mL
hs-CRP	Systemic inflammation; drives mitochondrial oxidative stress	Below 1.0 mg/L
Oxidized LDL	LDL oxidation status; CoQ10 protects against LDL oxidation	Below 60 U/L
IGF-1	GH axis function; mitochondrial biogenesis signaling	Upper third of age range
Vitamin D	Mitochondrial function cofactor; immune and bone health	60 to 80 ng/mL

6. Symptoms Associated With CoQ10 Depletion

7. What Causes Low CoQ10

• Statin medications: the most common cause of CoQ10 depletion in clinical practice. Statins inhibit HMG-CoA reductase, reducing CoQ10 synthesis by 40 to 50%. The depletion is dose-dependent: higher-potency statins (atorvastatin, rosuvastatin) produce greater CoQ10 reduction
• Aging: endogenous CoQ10 production declines progressively after age 20. Heart tissue CoQ10 concentrations decrease approximately 50% between ages 20 and 80. This decline parallels the increase in fatigue, reduced exercise capacity, and cardiovascular risk seen with aging
• Increased oxidative stress: chronic inflammation and oxidative stress consume CoQ10 (as ubiquinol) faster than it can be regenerated, producing functional depletion even when synthesis is adequate
• Mitochondrial dysfunction: damaged mitochondria produce more ROS and consume more CoQ10 for antioxidant defense while simultaneously producing less ATP. This vicious cycle depletes CoQ10 reserves in mitochondrial dysfunction
• Beta-blockers: propranolol and other beta-blockers inhibit CoQ10-dependent enzymes and can reduce serum CoQ10 levels
• Diabetes medications: some sulfonylureas and other diabetes drugs reduce CoQ10 levels
• Inadequate dietary intake: CoQ10 is found in organ meats, beef, sardines, mackerel, peanuts, and spinach, but dietary sources typically provide only 3 to 6mg daily, far below therapeutic doses
• Genetic variants: rare primary CoQ10 deficiency syndromes involve mutations in CoQ10 biosynthesis genes; acquired deficiency from the above causes is far more common

8. How to Optimize CoQ10 Levels

9. Related Lab Tests

10. When Testing Is Recommended

• All patients on statin medications: baseline before or at initiation, then annually. CoQ10 supplementation should begin simultaneously with statin therapy
• Patients with unexplained fatigue, muscle pain, or exercise intolerance, particularly when on medications known to deplete CoQ10
• Heart failure evaluation and monitoring: CoQ10 is an evidence-based adjunctive therapy in heart failure
• Comprehensive mitochondrial and longevity assessment alongside fasting insulin, hs-CRP, IGF-1, and DHEA-S
• Patients with mitochondrial dysfunction symptoms: fatigue, post-exertional malaise, cognitive decline, poor exercise recovery
• Fertility evaluation: egg quality and sperm motility assessment
• Patients on beta-blockers, sulfonylureas, or other medications that reduce CoQ10
• Monitoring CoQ10 supplementation response at 8 to 12 weeks to confirm levels are in the therapeutic range

11. Clinical Perspective

12. Frequently Asked Questions